Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.39 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 3/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20407029 | 0.77 | LIPG (0.52) | LPLLIPGNPC1RAB9ADGAT1 | |
| SCHEMBL21781485 | 0.77 | LIPG (0.52) | LPLLIPGNPC1RAB9ADGAT1 | |
| SCHEMBL25709634 | 0.77 | LIPG (0.51) | LPLLIPGCYP17A1CYP11B1CYP11B2 | |
| SCHEMBL27254369 | 0.75 | NPC1 (0.41) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 | |
| SCHEMBL26154585 | 0.75 | ESR1 (0.37) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 | |
| SCHEMBL22841799 | 0.75 | NPC1 (0.44) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 | |
| SCHEMBL22842162 | 0.75 | NPC1 (0.44) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 | |
| SCHEMBL22841525 | 0.74 | PGR (0.36) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 | |
| SCHEMBL22486473 | 0.74 | LIPG (0.51) | LPLLIPGDGAT1 | |
| SCHEMBL22842161 | 0.73 | PGR (0.40) | NPC1RAB9ACYP17A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746093-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| US-20230192627-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746093-B2 | Nitrogen-containing compound, electronic element, and electronic device | SLC43A1, SLC7A5, L1CAM | LPL 4449/4885LIPG 1888/4885NPC1 2177/4885 |
| US-20230192627-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SLC43A1, SLC7A5, L1CAM | LPL 4449/4885LIPG 1888/4885NPC1 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.